Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$554M |
| 2 |
Broadcom
AVGO
|
+$378M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$324M |
| 4 |
Warner Bros
WBD
|
+$321M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$454M |
| 2 |
iShares MBS ETF
MBB
|
+$441M |
| 3 |
AT&T
T
|
+$266M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$198M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.98% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Recursion Pharmaceuticals
RXRX
$1.59B
| $3.49M | ﹤0.01% |
428,342
+55,178
| +15% | +$369K |
|
2352
Comtech Telecommunications
CMTL
$50.3M
| $3.48M | ﹤0.01% |
383,283
+52,268
| +16% | +$653K |
|
2353
Ocugen
OCGN
$416M
| $3.46M | ﹤0.01% |
1,522,635
+111,734
| +8% | +$267K |
|
2354
Coherus Oncology
CHRS
$217M
| $3.45M | ﹤0.01% |
475,997
+8,492
| +2% | +$73.8K |
|
|
CCRN
2355
DELISTED
Cross Country Healthcare
CCRN
| $3.44M | ﹤0.01% |
165,275
+42,349
| +34% | +$793K |
|
2356
Arrow Financial
AROW
$659M
| $3.43M | ﹤0.01% |
114,368
-3,666
| -3% | -$110K |
|
2357
Microvast
MVST
$269M
| $3.42M | ﹤0.01% |
1,541,575
+345,685
| +29% | +$1.48M |
|
2358
LegalZoom.com
LZ
$1.35B
| $3.42M | ﹤0.01% |
310,726
+201,551
| +185% | +$2.66M |
|
|
ATCO
2359
DELISTED
Atlas Corp.
ATCO
| $3.4M | ﹤0.01% |
317,744
+21,749
| +7% | +$273K |
|
2360
Claros Mortgage Trust
CMTG
$250M
| $3.4M | ﹤0.01% |
+203,164
| New | +$3.84M |
|
2361
RE/MAX Holdings
RMAX
$193M
| $3.4M | ﹤0.01% |
138,518
-414
| -0.3% | -$10.1K |
|
2362
Cytek Biosciences
CTKB
$545M
| $3.38M | ﹤0.01% |
315,256
+25,410
| +9% | +$253K |
|
2363
Astronics
ATRO
$3.43B
| $3.37M | ﹤0.01% |
397,493
+53,339
| +15% | +$481K |
|
2364
uniQure
QURE
$3.03B
| $3.35M | ﹤0.01% |
179,567
-2,109
| -1% | -$33.5K |
|
2365
Hackett Group
HCKT
$270M
| $3.34M | ﹤0.01% |
176,032
+13,130
| +8% | +$283K |
|
2366
Energy Vault
NRGV
$517M
| $3.33M | ﹤0.01% |
+332,113
| New | +$4.32M |
|
2367
Gossamer Bio
GOSS
$82.9M
| $3.33M | ﹤0.01% |
397,429
-10,126
| -2% | -$78.5K |
|
|
ALX
2368
Alexander's
ALX
$1.3B
| $3.32M | ﹤0.01% |
14,960
-490
| -3% | -$118K |
|
|
THR
2369
DELISTED
Thermon Group Holdings
THR
| $3.32M | ﹤0.01% |
236,446
-5,006
| -2% | -$77.2K |
|
|
SWI
2370
DELISTED
SolarWinds Corporation Common Stock
SWI
| $3.32M | ﹤0.01% |
323,556
+94,686
| +41% | +$1.12M |
|
|
TBRG
2371
DELISTED
TruBridge
TBRG
| $3.31M | ﹤0.01% |
103,670
-885
| -0.8% | -$28.6K |
|
|
DM
2372
DELISTED
Desktop Metal, Inc.
DM
| $3.31M | ﹤0.01% |
150,605
+14,710
| +11% | +$430K |
|
2373
Riot Platforms
RIOT
$7.63B
| $3.31M | ﹤0.01% |
789,136
+43,608
| +6% | +$405K |
|
|
RXDX
2374
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $3.3M | ﹤0.01% |
117,002
-3,749
| -3% | -$109K |
|
2375
Mercantile Bank Corp
MBWM
$1.04B
| $3.28M | ﹤0.01% |
102,587
-3,635
| -3% | -$118K |
|
Similar funds
Charles Schwab's Q2 2022 Portfolio in Review
As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
- Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
- Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
- Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
- Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
- Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
- Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.
Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.